New Research Poster Presentation 1.16: Effects of Aripiprazole on Metabolic Measures in Pediatric and Adolescent Patients: A Pooled Analysis of Placebo-Controlled Trials

Wednesday, October 28, 2009 10:00 AM

Andrei Pikalov, M.D., Ph.D., Otsuka America Pharmaceutical, Inc., Rockville, MD

Ross A. Baker, M.B.A., Ph.D., Bristol-Myers Squibb Company, Plainsboro, NJ

Stephen Kaplita, M.S., Bristol-Myers Squibb Company, Wallingford, CT

Jian Han, Ph.D., Bristol-Myers Squibb Company, Wallingford, CT

Randall Owen, M.D., Bristol-Myers Squibb Comopany, Wallingford, CT

Suja Mathew, B.S., Otsuka America Pharmaceutical, Inc., Rockville, MD

Raymond Mankoski, M.D., Ph.D., Bristol-Myers Squibb Company, Plainsboro, NJ

William Carson, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Robert A. Forbes, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Margaretta Nyilas, M.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

Taro Iwamoto, Ph.D., Otsuka America Pharmaceutical, Inc., Princeton, NJ

John W. Newcomer, M.D., Dept. of Psychiatry, Washington University School of Medicine, St. Louis, MO

		56th Annual Meeting Tentative Program Schedule
		Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.

New Research Poster Presentation 1.16 Effects of Aripiprazole on Metabolic Measures in Pediatric and Adolescent Patients: A Pooled Analysis of Placebo-Controlled Trials